GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis

Europe • Euronext Oslo • OSL:GENT • NO0010748866

57.2 NOK
-0.6 (-1.04%)
Last: Feb 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GENT. GENT was compared to 63 industry peers in the Health Care Equipment & Supplies industry. GENT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. GENT is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • GENT had positive earnings in the past year.
  • GENT had a positive operating cash flow in the past year.
  • In the past 5 years GENT reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
GENT.OL Yearly Net Income VS EBIT VS OCF VS FCFGENT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • With an excellent Return On Assets value of 18.38%, GENT belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
  • GENT has a better Return On Equity (21.18%) than 88.89% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.76%, GENT is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
ROA 18.38%
ROE 21.18%
ROIC 8.76%
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
GENT.OL Yearly ROA, ROE, ROICGENT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • GENT has a better Profit Margin (24.80%) than 93.65% of its industry peers.
  • The Operating Margin of GENT (13.44%) is better than 60.32% of its industry peers.
  • The Gross Margin of GENT (55.06%) is comparable to the rest of the industry.
  • GENT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.44%
PM (TTM) 24.8%
GM 55.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
GENT.OL Yearly Profit, Operating, Gross MarginsGENT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • GENT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, GENT has about the same amount of shares outstanding.
  • Compared to 5 years ago, GENT has about the same amount of shares outstanding.
  • Compared to 1 year ago, GENT has an improved debt to assets ratio.
GENT.OL Yearly Shares OutstandingGENT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
GENT.OL Yearly Total Debt VS Total AssetsGENT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • GENT has an Altman-Z score of 18.36. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 18.36, GENT belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
  • GENT has a debt to FCF ratio of 0.59. This is a very positive value and a sign of high solvency as it would only need 0.59 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.59, GENT belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that GENT is not too dependend on debt financing.
  • The Debt to Equity ratio of GENT (0.01) is better than 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.59
Altman-Z 18.36
ROIC/WACC1.03
WACC8.51%
GENT.OL Yearly LT Debt VS Equity VS FCFGENT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • GENT has a Current Ratio of 5.98. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
  • GENT has a better Current ratio (5.98) than 98.41% of its industry peers.
  • GENT has a Quick Ratio of 4.16. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of GENT (4.16) is better than 93.65% of its industry peers.
Industry RankSector Rank
Current Ratio 5.98
Quick Ratio 4.16
GENT.OL Yearly Current Assets VS Current LiabilitesGENT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 2066.40% over the past year.
  • GENT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.42%.
  • GENT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.96% yearly.
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 62.29% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, GENT will show a very strong growth in Revenue. The Revenue will grow by 31.72% on average per year.
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GENT.OL Yearly Revenue VS EstimatesGENT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
GENT.OL Yearly EPS VS EstimatesGENT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.95, the valuation of GENT can be described as rather expensive.
  • Based on the Price/Earnings ratio, GENT is valued cheaper than 82.54% of the companies in the same industry.
  • GENT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
  • Based on the Price/Forward Earnings ratio of 21.08, the valuation of GENT can be described as rather expensive.
  • GENT's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of GENT to the average of the S&P500 Index (27.86), we can say GENT is valued slightly cheaper.
Industry RankSector Rank
PE 20.95
Fwd PE 21.08
GENT.OL Price Earnings VS Forward Price EarningsGENT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 63.49% of the companies in the same industry are cheaper than GENT, based on the Enterprise Value to EBITDA ratio.
  • GENT's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. GENT is more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 271.48
EV/EBITDA 24.74
GENT.OL Per share dataGENT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as GENT's earnings are expected to grow with 62.29% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. Dividend

5.1 Amount

  • GENT has a yearly dividend return of 0.70%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.97, GENT has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.70, GENT pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.7%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
GENT.OL Yearly Income VS Free CF VS DividendGENT.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

More info and screens

Find the best dividend stocksShow peers with best dividend

GENTIAN DIAGNOSTICS ASA

OSL:GENT (2/9/2026, 7:00:00 PM)

57.2

-0.6 (-1.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners39.37%
Inst Owner ChangeN/A
Ins Owners2.6%
Ins Owner ChangeN/A
Market Cap882.02M
Revenue(TTM)172.52M
Net Income(TTM)42.78M
Analysts85.71
Price Target68.34 (19.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.7%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 20.95
Fwd PE 21.08
P/S 5.11
P/FCF 271.48
P/OCF 71.13
P/B 4.37
P/tB 5.2
EV/EBITDA 24.74
EPS(TTM)2.73
EY4.77%
EPS(NY)2.71
Fwd EY4.74%
FCF(TTM)0.21
FCFY0.37%
OCF(TTM)0.8
OCFY1.41%
SpS11.19
BVpS13.1
TBVpS11.01
PEG (NY)0.35
PEG (5Y)N/A
Graham Number28.37
Profitability
Industry RankSector Rank
ROA 18.38%
ROE 21.18%
ROCE 11.37%
ROIC 8.76%
ROICexc 15.22%
ROICexgc 21.01%
OM 13.44%
PM (TTM) 24.8%
GM 55.06%
FCFM 1.88%
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.59
Debt/EBITDA 0.06
Cap/Depr 101.32%
Cap/Sales 5.3%
Interest Coverage 250
Cash Conversion 38.48%
Profit Quality 7.6%
Current Ratio 5.98
Quick Ratio 4.16
Altman-Z 18.36
F-Score5
WACC8.51%
ROIC/WACC1.03
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y260.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y127.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y285.08%
OCF growth 3YN/A
OCF growth 5YN/A

GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ

Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.


Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a valuation rating of 4 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?

GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.


How financially healthy is GENTIAN DIAGNOSTICS ASA?

The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.


What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?

The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 59.41% in the next year.